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Purpose: The purpose of our study was to investigate the effects of hippotherapy 
on gross motor function and functional performance in children with spastic cere-
bral palsy (CP). Materials and Methods: We recruited 34 children (M:F=15:19, 
age: 3‒12 years) with spastic CP who underwent hippotherapy for 45 minutes 
twice a week for 8 weeks. Twenty-one children with spastic CP were recruited for 
control group. The distribution of gross motor function classification system level 
and mean age were not significantly different between the two groups. Outcome 
measures, including the Gross Motor Function Measure (GMFM)-66, GMFM-88 
and the Pediatric Evaluation of Disability Inventory: Functional Skills Scale 
(PEDI-FSS), were assessed before therapy and after the 8-weeks intervention as 
outcome measures. Results: There were no significant differences between inter-
vention and control groups in mean baseline total scores of GMFM-66, GMFM-
88 or PEDI-FSS. After the 8-weeks intervention, mean GMFM-66 and GMFM-88 
scores were significantly improved in both groups. However, the hippotherapy 
group had significantly greater improvement in dimension E and GMFM-66 total 
score than the control group. The total PEDI-FSS score and the sub-scores of its 3 
domains were significantly improved in the hippotherapy group, but not in the 
control group. Conclusion: The results of our study demonstrate the beneficial ef-
fects of hippotherapy on gross motor function and functional performance in chil-
dren with CP compared to control group. The significant improvement in PEDI-
FSS scores suggests that hippotherapy may be useful to maximize the functional 
performance of children with CP.
Key Words:   Cerebral palsy, spastic, hippotherapy, function, physical activity, dis-
ability evaluation 
INTRODUCTION
Cerebral palsy (CP) refers to a group of permanent motor disorders attributed to a 
non-progressive lesion that occurs in the immature brain.1 Children with CP have 
various degrees of impairment of movement and posture, which can limit physical 
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MATERIALS AND METHODS
Participants
Children with spastic CP who met the inclusion and exclu-
sion criteria were recruited for this study. The inclusion cri-
teria were as follows: 1) age 3 to 12 years, 2) body weight 
less than 40 kg, and 3) gross motor function classification 
system (GMFCS) level I to IV. The exclusion criteria were 
as follows: 1) chemodenervation therapy in the previous 6 
months, 2) selective dorsal rhizotomy within the past year, 
3) moderate to severe intellectual disability, 4) uncontrolled 
seizure, 5) poor visual or hearing acuity, and 6) previous 
participation in hippotherapy or THR.
We asked the parents of the recruited children who met 
inclusion and exclusion criteria whether they desired hippo-
therapy for their children and could feasibly attend riding 
sessions. The parents of 45 children agreed to participate. 
During this study, 5 children dropped out for various rea-
sons, such as acute illness or injury unrelated to hippothera-
py. Another 6 children did not complete the Gross Motor 
Function Measure (GMFM) assessment after hippotherapy. 
Thus, data from a total of 34 children (15 boys and 19 girls) 
were used to investigate the effects of hippotherapy. 
As controls, we recruited 21 children with CP who were 
waiting to begin hippotherapy or whose parents could not 
attend hippotherapy for various reasons such as scheduling 
problems. The children in both experimental and control 
groups had been attending a 30-minute session of outpa-
tient physical and occupational therapy once a week. This 
study was approved by the Institutional Review Board and 
Ethics Committee of Severance Hospital (# 4-2010-0069).
 
Sample size
Sample size was selected on the basis of a previous report 
by Sterba, et al.,17 which demonstrated significant gains in 
GMFM scores after horseback riding therapy in children 
with CP. A sample size of 13 would achieve 80% power to 
detect a difference of 8.6 with a known standard deviation 
of 11 and with a significance level (α) of 0.05 using a two-
sided one-sample t-test. Assuming a 20% loss to follow-up, 
at least 19 children were needed for each group. 
Outcome measures
The GMFM and the Pediatric Evaluation of Disability Inven-
tory-Functional Skills Scale (PEDI-FSS) were selected as 
outcome measures because both are commonly used in chil-
activity and participation in daily life.2,3 
Two types of horseback riding therapy are widely avail-
able: hippotherapy and therapeutic horseback riding (THR). 
In hippotherapy, a physical or occupational therapist con-
trols the horse to influence the child’s posture, balance, co-
ordination, strength and sensorimotor systems while the 
child interacts with the horse and responds to the move-
ment of the horse.4-6 In contrast, THR is led by a trained rid-
ing instructor with the child actively controlling the horse 
as a form of exercise to improve coordination, balance and 
posture, and to encourage development of sensory and per-
ceptual motor skills.5,7,8 Although there are some differenc-
es between hippotherapy and THR, their therapeutic goals 
are essentially the same for children with CP. The warmth 
and shape of the horse and the rhythmic, three-dimensional 
movement of horseback riding are believed to improve the 
flexibility, posture, balance and mobility of the rider. 
The potential for horseback riding therapy to promote 
gross motor function in children with CP has been investigat-
ed previously with mixed results. Some reports demonstrated 
the benefits of horseback riding therapy on reducing abnor-
mal tone, promoting motor performance, creating symmetric 
alignment and improving postural awareness, gait and mo-
bility.9-12 However, other reports found no significant effects 
of horseback riding therapy.10,13-15 This discrepancy of re-
sults may be due to differences in study design, participant 
characteristics and functional level, sample size, and inten-
sity and duration of therapy given. Most studies on this sub-
ject had small sample sizes, ranging from 3 to 17 cases 
without control groups for comparison.5 There are, howev-
er, two randomized controlled trials with 72 participants 
and 19 participants, respectively. However, both found no 
significant benefits of horseback riding therapy for children 
with CP.10,13 A published meta-analysis concluded that there 
was insufficient evidence to support the benefits of horse-
back riding therapy on gross motor function.16 
Despite this lack of consistent evidence on the benefit, 
horseback riding therapy is often recommended by clini-
cians for children with CP to improve gross motor function. 
Further evidence is required to support this practice. In ad-
dition, the ultimate therapeutic goal for children with CP is 
to enhance functional performance in daily life. However, 
the effects of horseback riding therapy on functional perfor-
mance in particular have rarely been studied. Therefore, the 
aim of this study is to evaluate the effects of additional hip-
potherapy on gross motor function and functional perfor-
mance in daily life of children with CP. 
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the parent or caregiver. All items were checked as either ca-
pable (score 1) or unable (score 0). No items were left blank. 
Both the GMFM and PEDI-FSS were assessed within the 
week before and again within 2 months after completion of 
the 8-week intervention in both groups. 
Hippotherapy
On review of the literature, hippotherapy intervention pro-
tocols vary between studies in intensity and duration. In the 
studies cited, session length ranged from 30 minutes to 1 
hour with a frequency ranging from 1‒2 sessions per week 
and the total duration of horseback riding ranged widely 
from 8 min and 26 hours. According to a recent systematic 
review, a weekly 45-min session of either THR or hippo-
therapy for 8‒10 weeks was correlated with positive effects 
on gross motor function in children with CP.5 Given these 
results, we administered 45-minutes sessions twice per week 
for 8 weeks in this study.
Hippotherapy was performed at the riding center in Seoul 
Race Park of the Korea Racing Authority. The sessions were 
conducted by a trained occupational therapist accredited by 
the American Hippotherapy Association while the horse 
was led by a trained assistant. A volunteer walked along ei-
ther side of the horse to assist the child. The therapist fol-
lowed target objectives aimed to develop the child’s senso-
rimotor and perceptual-motor skills. The child was seated 
astride the horse wearing a helmet and was encouraged to 
perform various activities designed to emphasize movement 
in a forward and upward reaching direction to encourage ac-
tive postural control, trunk strength, balance and trunk/pel-
vic dissociation. 
Statistical analysis
Statistical analysis was performed using SPSS 19.0 for Win-
dows (SPSS Inc., Chicago, IL, USA). The independent t-test 
was used to compare the difference in mean age between 
groups. The chi-squared test was used to compare the differ-
ences in distributions of GMFCS level and age between 
groups. Paired and independent t-tests were used to assess 
differences within and between groups, respectively. A p-
value less than 0.05 was considered statistically significant.
 
RESULTS
 
Patient characteristics are summarized in Table 1. Of the 34 
children in the intervention group, 32 had bilateral spastic 
dren with CP18 and meet the criteria for reliability and validity 
with respect to responsiveness to change.19 The GMFM as-
sesses the capacity of the International Classification of 
Function (ICF), while the PEDI-FSS measures performance 
in functional activities of daily life. When used together, the 
GMFM and PEDI provide a comprehensive picture of a 
child’s functional abilities at the ICF activities level.19
Primary outcome measure
The GMFM is a tool used to measure the child’s capacity for 
gross motor function. Capacity refers to a person’s underly-
ing ability to perform in a standardized environment.20 It has 
been widely used to measure changes in gross motor func-
tion over time and the effectiveness of interventions. Items 
on the GMFM-88 are grouped into five dimensions: A: lying 
and rolling (17 items); B: sitting (20 items); C: crawling and 
kneeling (14 items); D: standing (13 items); and E: walking, 
running and jumping (24 items). The GMFM-66 was devel-
oped using Rasch analysis of the GMFM-88, whereby 22 of 
the original 88 items were deleted to improve reliability and 
validity.21 Of the 22 items deleted, 13 were from the lying 
and rolling dimension, 5 were from the sitting dimension 
and 4 were from the kneeling and crawling dimension. The 
GMFM-66 represents the unidimensional construct of gross 
motor ability according to task difficulty and thus is recom-
mended for research purposes when comparing changes in 
gross motor function over time in children with CP.22 How-
ever, the GMFM-66 is much less useful when scoring chil-
dren with a severe disability.23 Therefore, both the GMFM-
66 and GMFM-88 were used to assess gross motor function 
in this study. 
Secondary outcome measure 
The PEDI is an internationally recognized, validated paren-
tal report measure used for assessing a child’s capability 
and performance in daily life. Capability describes what a 
person potentially can do, whereas performance describes 
what a person actually does in their environment.20 Capabil-
ity is measured by identifying mastery of functional skills 
in three domains: self-care, mobility and social functioning. 
Performance is measured by parental reports of whether the 
child is capable of performing each of 197 tasks in these 3 
domains in daily environments, such as home and kinder-
garten or school.18 In this study, we used only the PEDI-FSS 
to measure the child’s actual performance in those three do-
mains. The PEDI-FSS evaluation was performed by trained 
occupational therapists through a structured interview with 
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of any domain between groups. After the 8-week interven-
tion, significant improvements in the total score and the 
sub-scores of all 3 domains were achieved in the hippother-
apy group, but not in the control group. In addition, chang-
es in the total score and sub-scores of all 3 domains after 
the 8-week study period were significantly greater in the 
hippotherapy group than the control group (Table 3). 
DISCUSSION
The GMFM is commonly used to measure changes in 
gross motor function as a result of horseback riding therapy. 
Previous studies have used the total or dimension scores of 
the GMFM-88 more often than the GMFM-66.11,13,14 Re-
peated measures analysis among participants demonstrated 
significant gains in GMFM-88 scores after horseback rid-
ing therapy in most published studies.11,17,24 In contrast, two 
randomized controlled trial (RCT) studies did not demon-
strate any significant gains in the GMFM-88 or GMFM-
66.10,13,14
In our study, significant gains in the GMFM-88 and 
GMFM-66 were demonstrated in both groups. In children 
with CP, the most rapid improvements in GMFM scores 
occur during the first 4 years of age, with children reaching 
a plateau between 5 and 6 years, depending on the severity 
CP and 2 had unilateral CP. There was no significant differ-
ence in mean age, distribution, or GMFCS level between 
groups. Young children aged 3 to 7 years comprised 22 in-
dividuals in the hippotherapy group and 10 in the control 
group. The proportion of younger or older children was not 
significantly different between groups.
At the initial baseline evaluation, there were no signifi-
cant differences in total GMFM-66 or GMFM-88 score be-
tween hippotherapy and control groups. However, GMFM-
88 scores in the B and C dimensions were significantly 
higher in the hippotherapy group than the control group. Af-
ter the 8-week intervention, both GMFM-66 and GMFM-88 
scores were significantly improved in both groups. The im-
provements in GMFM-66 scores were significantly greater 
in the hippotherapy group than in the control group. GMFM-
88 scores were significantly improved in all dimensions in 
the hippotherapy group, but only in dimension B in the 
control group. Changes in dimension E of the GMFM-88 
over the course of the study were significantly greater in the 
hippotherapy group than in the control group (Table 2).
PEDI-FSS evaluations were missing in 6 children in the 
hippotherapy group because their parents could not be in-
terviewed for various reasons. Thus, PEDI-FSS was as-
sessed in 28 children in the hippotherapy group and 21 in 
the control group. At the initial baseline evaluation, there 
were no significant differences in total score or sub-scores 
Table 1. Participant Characteristics 
Hippotherapy (n=34) Control (n=21)
Age (mean±SD, range; yrs) 6.68±2.64 (3‒12) 7.76±3.67 (3‒14)
    3≤age<7 (number, %)  22 (64.7)  10 (47.6)
    7≤age<13 (number, %)  12 (35.3)  11 (52.4)
Sex (M:F)   15:19   10:11
Distribution (bilateral:unilateral) 32:2 19:2
GMFCS level (I:II:III:IV) 8:11:5:10 6:4:6:5
GMFCS, gross motor function classification system.
Table 2. Changes in Gross Motor Function Measure (GMFM) Scores 
Hippotherapy (n=34) Control (n=21)
Pre Post Post-Pre Pre Post Post-Pre
GMFM-66 (%) 58.49±13.40 61.43±14.78* 2.93±3.95† 61.20±21.69 62.46±21.70* 1.25±1.99
GMFM-88 (%) 71.50±20.69 73.59±20.41* 2.09±2.87 63.80±28.33 64.85±27.51* 1.05±1.70
    A (%) 97.65±5.20 98.29±4.35* 0.65±1.54 97.90±4.13 98.20±3.72 0.30±1.34
    B (%) 87.53±18.68 89.38±16.73* 1.85±4.26 65.75±26.62 67.50±26.16* 1.75±3.46
    C (%) 77.59±24.25 79.91±23.48* 2.32±4.23 59.60±35.68 61.25±33.85 1.65±4.05
    D (%) 52.12±33.19 55.12±33.91* 3.00±6.56 50.95±44.89 51.55±44.33 0.60±1.57
    E (%) 44.18±33.31 45.26±33.90* 3.09±4.50† 44.45±45.14 45.25±44.96 0.80±2.21
*p<0.05, significant change after intervention by paired t-test. 
†p<0.05, significant pre-post intervention difference compared to controls by independent sample t-test. 
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CP. Unfortunately, however, the sample size of our study 
was too small to divide into groups according to GMFCS 
level, thus preventing us from analyzing changes in the 
GMFM according to functional level. Further study is war-
ranted with larger sample sizes to explore changes in gross 
motor function according to GMFCS level.
The PEDI-FSS has been widely used to evaluate the dai-
ly functional performance of children with CP.18 The PEDI 
is intended for children up to 7.5 years of age, but this can 
be extended to children with functional disabilities.26 In our 
study, the PEDI-FSS was used to measure the actual perfor-
mance in daily life of children older than 7.5 years. On re-
view of the literature, the PEDI was used as an outcome 
measure in only one study by Casady and Nichols-Larsen.11 
In that study, significant improvement was found in the to-
tal PEDI score as well as its 3 domains of self-care, mobili-
ty and social functioning. However, the small sample size 
(n=10), lack of a control group and large variability in the 
frequency of physical, occupational and speech therapy 
(none-10 weeks) limits the applicability of these results. 
Our study demonstrated significant improvements in all 3 
PEDI domains of self-care, mobility and social functioning 
in the hippotherapy group, but not in the control group. 
These findings suggest some positive effects of hippothera-
py on the child’s actual performance in daily life. The mo-
bility domain is closely related to gross motor function 
based on GMFCS level,27 while the self-care domain is re-
lated to both GMFCS level and hand function based on 
Manual Ability Classification System score.28 According to 
a previous report, hippotherapy improved dynamic trunk 
stability and functional reach in children with spastic diple-
gia.12 Those beneficial effects of hippotherapy seem likely 
to contribute the significant gains of self-care and mobility 
domains in our study.
The social functioning domain is influenced by various 
factors such as education, socioeconomic status, cognition, 
communication abilities and motor function.27 The opportu-
nity to use or practice communication, listening and language 
of their disability.1 A proportion of children in each group 
were aged from 3 to 7 years, making it possible that gains 
were naturally occurring. In the present study, however, the 
significantly greater gains in GMFM-66 score and dimen-
sion E of GMFM-88 in the hippotherapy group suggest the 
beneficial effects of hippotherapy on gross motor function.
Of the previous studies showing significant gains in the 
GMFM, 3 studies reported significant improvement only in 
dimension E17,24,25 and one study reported significant gains 
in all dimensions except A.11 The dimension of GMFM im-
proved by horseback riding therapy may vary according to 
the initial functional level of participants. To the best of our 
knowledge, only 5 reports have been published describing 
the GMFCS level of participants.13-15,17,25 Among those stud-
ies, the GMFM was used as an outcome measure in 3 stud-
ies.13,17,25 A RCT study in which all participants were at GM-
FCS level I to III13 did not find any significant improve-
ments in the intervention group compared to controls. In 
contrast, a repeated measure within-participant study re-
ported significant gains in total GMFM-88 and dimension 
E scores.17 In that study, 12 of the 17 participating children 
were GMFCS level I to III and only 5 were level IV to V. 
Another study in which all participants were GMFCS level I 
to II reported significant improvements in GMFM dimension 
E in the hippotherapy group, compared to control group.25 
These cumulative data suggest that horseback riding thera-
py leads to improvements in dimension E of the GMFM, 
especially in higher functioning children. 
Our study demonstrated significantly greater improvement 
in GMFM-66 and dimension E scores in the hippotherapy 
group and no significant difference in GMFM-88 scores 
gains between groups. The deletions from the GMFM-88 to 
create the GMFM-66 (13 items from dimension A, 5 items 
from dimension B and 4 items from dimension C) may 
have influenced the greater gain observed in GMFM-88 di-
mension E and GMFM-66 in the hippotherapy group. Our 
findings are consistent with the hypothesis that hippothera-
py is more beneficial in higher-functioning children with 
Table 3. Changes in Pediatric Evaluation of Disability Inventory (PEDI) Scores
Hippotherapy (n=28) Control (n=21)
Pre Post Post-Pre Pre Post Post-Pre
PEDI 116.32±48.61 127.21±46.89* 10.89±11.94† 112.52±64.98 114.52±64.53 2.00±4.93
    Self care   43.61±18.87   46.25±17.93* 2.64±3.76†   40.81±24.04   41.33±24.13 0.52±1.40
    Mobility   29.29±18.49   33.43±18.76* 4.14±6.10†   29.57±22.37   30.00±22.44 0.43±0.98
    Social functioning   43.43±16.38   47.54±16.19* 4.10±5.58†   42.14±23.76   43.19±22.80 1.05±2.71
*p<0.05, significant change after intervention by paired t-test. 
†p<0.05, significant pre-post intervention difference compared to controls by independent sample t-test.
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